(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1547380

エクソソーム技術の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Exosome Technologies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 181 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.06円
エクソソーム技術の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

エクソソーム技術市場の世界需要は、2023年の6,642万米ドルから2032年には5億1,004万米ドル近くの市場規模に達すると推定され、調査期間2024～2032年のCAGRは25.42%です。

エクソソーム技術は、細胞間コミュニケーションに不可欠な役割を果たす細胞から放出される小さな細胞外小胞であるエクソソームの利用に焦点を当てています。これらの小胞はタンパク質、脂質、遺伝物質を運び、様々な生理学的・病理学的プロセスに影響を与えます。診断学と治療学では、エクソソームの単離、特性解析、応用が含まれます。診断学では、エクソソームはがんや神経変性疾患のバイオマーカーとなり得る。治療としては、特定の標的細胞に治療分子を送達できることから、ドラッグデリバリーや再生医療への応用が検討されています。これらの技術の進歩は、個別化医療や新たな治療戦略への応用が期待されています。

市場力学

診断と治療におけるエクソソームの可能性に対する関心の高まりが、エクソソーム技術市場の成長を促進しています。エクソソームは生体分子の天然キャリアとして、非侵襲的な疾患検出とモニタリングの手段を提供し、これは特にがん診断やその他の医療セグメントで価値があります。分離と特性化技術の進歩は、エクソソーム別のアプリケーションの有効性と信頼性を高め、市場の成長をさらに促進します。慢性疾患の負担増と効果的な治療オプションの必要性も、市場の成長を後押ししています。さらに、バイオテクノロジー企業や研究機関による研究開発への多額の投資は、技術革新を加速させ、エクソソームベースの製品の潜在的用途を拡大しています。規制当局の承認と臨床試験の支援は、エクソソーム技術の商業化に資する環境を提供しています。エクソソームをベースとした診断薬や治療を個々の患者のプロファイルに合わせることができる個別化医療への注目の高まりも、市場の成長を促進する要因です。さらに、生物学的障壁を越えて治療を輸送するエクソソームの能力により、ドラッグ・デリバリー・システムにおけるエクソソームの可能性が大きな注目と投資を集め、エクソソーム技術市場の堅調な成長に寄与しています。しかし、大規模生産、分離技術の標準化、規制当局の承認プロセスにおける課題が、今後数年間の市場成長の妨げになる可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、エクソソーム技術の世界市場における各セグメントを包括的に評価することもできます。エクソソーム技術産業の成長と動向は、この調査に全体的なアプローチを記載しています。

市場セグメンテーション

エクソソーム技術市場レポートのこのセクションでは、国と地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家がそれぞれの製品またはサービスの対象層を特定する上で、今後の機会を支援します。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカにおけるエクソソーム技術市場の現在と将来の需要を強調する地域展望をカバーします。さらに、すべての主要地域における個々の用途セグメントの需要、推定・予測にも焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 エクソソーム技術-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 エクソソーム技術の世界市場分析：エクソソームタイプ別

  • エクソソームタイプ別概要
  • エクソソームタイプ別過去・予測データ分析
  • ロードカーゴ（ペプチド、SIRNA、mRNA、miRNA、タンパク質、化学品、その他）
  • ノンカーゴ

第6章 エクソソーム技術の世界市場分析：細胞源別

  • 細胞源別概要
  • 細胞源別過去・予測データ分析
  • HEK293細胞
  • 間葉系幹細胞
  • 血小板
  • 赤血球
  • 天然キラー細胞
  • その他

第7章 エクソソーム技術の世界市場分析：用途別

  • 用途別概要
  • 用途別過去・予測データ分析
  • 治療（がん、神経変性疾患、心血管疾患、感染症、化粧品、その他）
  • 診断薬

第8章 エクソソーム技術の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去・予測データ分析
  • 医療プロバイダー
  • 製薬・バイオテクノロジー企業
  • その他

第9章 エクソソーム技術の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 エクソソーム技術企業の競合情勢

  • エクソソーム技術市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Aegle Therapeutics
  • Aruna Bio Inc.
  • Bio-Techne Corporation
  • Carmine Therapeutics Inc.
  • Codiak BioSciences Inc.
  • Creative Biolabs
  • Danaher Corporation（Beckman Coulter Inc）
  • Fujifilm Holdings Corporation
  • NOVADIP Biosciences S.A.
  • OmniSpirant Limited
  • Thermo Fisher Scientific Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Exosome Type (USD MN)
  • Loaded Cargos (Peptide, SIRNA, mRNA, miRNA, Protein, Chemical, Others) Market Sales By Geography (USD MN)
  • Non-cargo Market Sales By Geography (USD MN)
  • Analysis By Cell Source (USD MN)
  • HEK293 Cells Market Sales By Geography (USD MN)
  • MSCs Market Sales By Geography (USD MN)
  • Platelets Market Sales By Geography (USD MN)
  • Erythrocytes Market Sales By Geography (USD MN)
  • Natural Killer Cells Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Therapeutics (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Cosmetics, Others) Market Sales By Geography (USD MN)
  • Diagnostics Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Health Care Providers Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Exosome Technologies Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Exosome Technologies Report
  • Market Research Process
  • Market Research Methodology
  • Global Exosome Technologies Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Exosome Type
  • Market Attractiveness Analysis By Cell Source
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Exosome Type (USD MN)
  • Loaded Cargos (Peptide, SIRNA, mRNA, miRNA, Protein, Chemical, Others) Market Sales By Geography (USD MN)
  • Non-cargo Market Sales By Geography (USD MN)
  • Global Market Analysis By Cell Source (USD MN)
  • HEK293 Cells Market Sales By Geography (USD MN)
  • MSCs Market Sales By Geography (USD MN)
  • Platelets Market Sales By Geography (USD MN)
  • Erythrocytes Market Sales By Geography (USD MN)
  • Natural Killer Cells Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Therapeutics (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Cosmetics, Others) Market Sales By Geography (USD MN)
  • Diagnostics Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Health Care Providers Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11215742

The global demand for Exosome Technologies Market is presumed to reach the market size of nearly USD 510.04 Million by 2032 from USD 66.42 Million in 2023 with a CAGR of 25.42% under the study period 2024-2032.

Exosome technologies focus on the utilization of exosomes, which are small extracellular vesicles released by cells that play an integral role in cell-to-cell communication. These vesicles carry proteins, lipids, and genetic material, influencing various physiological and pathological processes. It encompasses their isolation, characterization, and application in diagnostics and therapeutics. In diagnostics, exosomes can be biomarkers for cancer and neurodegenerative disorders. Therapeutics are explored for drug delivery and regenerative medicine, as they can deliver therapeutic molecules to specific target cells. Advances in these technologies hold promise for personalized medicine and novel treatment strategies.

MARKET DYNAMICS

The increasing interest in exosomes for their potential in diagnostics and therapeutics is driving the growth of the exosome technologies market. Exosomes, as natural carriers of biomolecules, offer a non-invasive means of disease detection and monitoring, which is particularly valuable in cancer diagnostics and other medical fields. Advancements in isolation and characterization techniques enhance the efficacy and reliability of exosome-based applications, further propelling market growth. The rising burden of chronic diseases and the need for effective treatment options also boost market growth. Furthermore, significant investments in research and development by biotech companies and research institutions are accelerating innovations and expanding the potential applications of exosome-based products. Regulatory approvals and support for clinical trials provide a conducive environment for the commercialization of exosome technologies. The increasing focus on personalized medicine, where exosome-based diagnostics and therapeutics can be tailored to individual patient profiles, is another factor driving market growth. Additionally, the potential of exosomes in drug delivery systems, due to their ability to transport therapeutic agents across biological barriers, garners significant attention and investment, contributing to the robust growth of the exosome technologies market. However, challenges in large-scale production, standardization of isolation techniques, and regulatory approval processes may hinder market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Exosome Technologies. The growth and trends of Exosome Technologies industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Exosome Technologies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Exosome Type

  • Loaded Cargos (Peptide, SIRNA, mRNA, miRNA, Protein, Chemical, Others)
  • Non-cargo

By Cell Source

  • HEK293 Cells
  • MSCs
  • Platelets
  • Erythrocytes
  • Natural Killer Cells
  • Others

By Application

  • Therapeutics (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Cosmetics, Others)
  • Diagnostics

By End-user

  • Health Care Providers
  • Pharmaceutical & Biotechnology Companies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Exosome Technologies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Exosome Technologies market include Aegle Therapeutics, Aruna Bio Inc., Bio-Techne Corporation, Carmine Therapeutics Inc., Codiak BioSciences Inc., Creative Biolabs, Danaher Corporation (Beckman Coulter Inc), Fujifilm Holdings Corporation, NOVADIP Biosciences S.A., OmniSpirant Limited, Thermo Fisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. EXOSOME TECHNOLOGIES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Exosome Type
    • 3.7.2 Market Attractiveness Analysis By Cell Source
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-user
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY EXOSOME TYPE

  • 5.1. Overview By Exosome Type
  • 5.2. Historical and Forecast Data Analysis By Exosome Type
  • 5.3. Loaded Cargos (Peptide, SIRNA, mRNA, miRNA, Protein, Chemical, Others) Historic and Forecast Sales By Regions
  • 5.4. Non-cargo Historic and Forecast Sales By Regions

6. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY CELL SOURCE

  • 6.1. Overview By Cell Source
  • 6.2. Historical and Forecast Data Analysis By Cell Source
  • 6.3. HEK293 Cells Historic and Forecast Sales By Regions
  • 6.4. MSCs Historic and Forecast Sales By Regions
  • 6.5. Platelets Historic and Forecast Sales By Regions
  • 6.6. Erythrocytes Historic and Forecast Sales By Regions
  • 6.7. Natural Killer Cells Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Therapeutics (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Cosmetics, Others) Historic and Forecast Sales By Regions
  • 7.4. Diagnostics Historic and Forecast Sales By Regions

8. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-user
  • 8.2. Historical and Forecast Data Analysis By End-user
  • 8.3. Health Care Providers Historic and Forecast Sales By Regions
  • 8.4. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EXOSOME TECHNOLOGIES COMPANIES

  • 10.1. Exosome Technologies Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF EXOSOME TECHNOLOGIES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Aegle Therapeutics
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Aruna Bio Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Bio-Techne Corporation
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Carmine Therapeutics Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Codiak BioSciences Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Creative Biolabs
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Danaher Corporation (Beckman Coulter Inc)
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Fujifilm Holdings Corporation
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. NOVADIP Biosciences S.A.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. OmniSpirant Limited
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Thermo Fisher Scientific Inc
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies